Monday, February 23, 2015 2:52:20 PM
Take the time to investigate the scientific board of Propanc. These fellows are top tier researchers, with experience taking numerous drugs through FDA approval and into the marketplace with great success.
Propanc's scientific board and board of directors also know their drug PRP is revolutionary and I am not surprised they are have trouble reaching a agreement with potential financiers. The terms of agreement have to be right for Propanc because they know they have a drug that will substantially improve the treatment of cancer.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM